FDA Approves Sientra’s Low Plus Profile Projection Breast Implant
06 juil. 2022 09h00 HE
|
Sientra, Inc.
SANTA BARBARA, Calif., July 06, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”) announced today that the U.S. Food and Drug Administration (FDA) approved the Low...
Sientra To Present At The William Blair 42nd Annual Growth Stock Conference
23 mai 2022 09h00 HE
|
Sientra, Inc.
SANTA BARBARA, Calif., May 23, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), announced today its participation at the William Blair 42nd Annual Growth Stock...
Sientra To Participate At The 19th Annual Craig-Hallum Institutional Investor Conference
18 mai 2022 16h30 HE
|
Sientra, Inc.
SANTA BARBARA, Calif., May 18, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), announced today its participation at the Virtual 19th Annual Craig-Hallum...
Sientra Reports Seventh Consecutive Quarter of Record Growth for First Quarter 2022
12 mai 2022 16h05 HE
|
Sientra, Inc.
Record Growth Driven by Continued Expansion of Augmentation and Reconstruction Accounts Accelerated Gross Margin Improvement Through Execution of Commercial and Operational Plans SANTA BARBARA,...
Sientra to Report First Quarter 2022 Financial Results on May 12, 2022
03 mai 2022 17h30 HE
|
Sientra, Inc.
SANTA BARBARA, Calif., May 03, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of...
Sientra to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on March 28th – 30th from 9:00 a.m. - 5:00 p.m. EDT
24 mars 2022 16h15 HE
|
Sientra, Inc.
SANTA BARBARA, Calif., March 24, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of...
Sientra Receives Regulatory Approval to Market Breast Implants in Canada
24 mars 2022 08h00 HE
|
Sientra, Inc.
SANTA BARBARA, Calif., March 24, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of...
Sientra Reports Record Plastic Surgery Revenue for Both Fourth Quarter and Full Year 2021
23 mars 2022 16h10 HE
|
Sientra, Inc.
Sixth Consecutive Quarter of Record Growth Doubled Augmentation and Reconstruction Market Share Since 2019 Broadened Market Opportunity with Addition of Novel, FDA-Cleared Fat...
Sientra to Report Fourth Quarter and Full Year 2021 Financial Results on March 23, 2022
09 mars 2022 16h05 HE
|
Sientra, Inc.
SANTA BARBARA, Calif., March 09, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of...
Sientra Reports Record Preliminary Unaudited Fourth Quarter and Full Year 2021 Revenues
10 janv. 2022 08h00 HE
|
Sientra, Inc.
Estimates highest ever Breast Products yearly revenue of $80-$81 million representing 46%-47% full year growth Results driven by continued strong demand for Sientra Breast Products and commercial...